These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24928479)

  • 21. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
    Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP
    Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI.
    Goudriaan AE; Veltman DJ; van den Brink W; Dom G; Schmaal L
    Addict Behav; 2013 Feb; 38(2):1509-1517. PubMed ID: 22591950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study.
    Baldwin DS; Huusom AK; Maehlum E
    Br J Psychiatry; 2006 Sep; 189():264-72. PubMed ID: 16946363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of acute bupropion pre-treatment on the effects of intranasal cocaine.
    Stoops WW; Lile JA; Glaser PE; Hays LR; Rush CR
    Addiction; 2012 Jun; 107(6):1140-7. PubMed ID: 22168398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
    Sugarman DE; Poling J; Sofuoglu M
    Pharmacol Biochem Behav; 2011 Mar; 98(1):94-100. PubMed ID: 21176784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Wade A; Michael Lemming O; Bang Hedegaard K
    Int Clin Psychopharmacol; 2002 May; 17(3):95-102. PubMed ID: 11981349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute behavioral and physiological effects of modafinil in drug abusers.
    Rush CR; Kelly TH; Hays LR; Baker RW; Wooten AF
    Behav Pharmacol; 2002 Mar; 13(2):105-15. PubMed ID: 11981223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine Transporter Correlates and Occupancy by Modafinil in Cocaine-Dependent Patients: A Controlled Study With High-Resolution PET and [(11)C]-PE2I.
    Karila L; Leroy C; Dubol M; Trichard C; Mabondo A; Marill C; Dubois A; Bordas N; Martinot JL; Reynaud M; Artiges E
    Neuropsychopharmacology; 2016 Aug; 41(9):2294-302. PubMed ID: 26892922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors.
    Mahler SV; Hensley-Simon M; Tahsili-Fahadan P; LaLumiere RT; Thomas C; Fallon RV; Kalivas PW; Aston-Jones G
    Addict Biol; 2014 Jan; 19(1):49-60. PubMed ID: 23017017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
    Wingen M; Kuypers KP; Ramaekers JG
    Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
    Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
    Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modafinil for the treatment of cocaine dependence.
    Anderson AL; Reid MS; Li SH; Holmes T; Shemanski L; Slee A; Smith EV; Kahn R; Chiang N; Vocci F; Ciraulo D; Dackis C; Roache JD; Salloum IM; Somoza E; Urschel HC; Elkashef AM
    Drug Alcohol Depend; 2009 Sep; 104(1-2):133-9. PubMed ID: 19560290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Plebani JG; Pettinati HM; Sparkman T; O'Brien CP
    J Subst Abuse Treat; 2012 Oct; 43(3):303-12. PubMed ID: 22377391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modafinil and cocaine interactions.
    Malcolm R; Swayngim K; Donovan JL; DeVane CL; Elkashef A; Chiang N; Khan R; Mojsiak J; Myrick DL; Hedden S; Cochran K; Woolson RF
    Am J Drug Alcohol Abuse; 2006; 32(4):577-87. PubMed ID: 17127546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of phendimetrazine maintenance on the reinforcing, subjective, performance, and physiological effects of intranasal cocaine.
    Stoops WW; Strickland JC; Alcorn JL; Hays LR; Rayapati AO; Lile JA; Rush CR
    Psychopharmacology (Berl); 2019 Sep; 236(9):2569-2577. PubMed ID: 30900008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardiovascular safety profile of escitalopram.
    Thase ME; Larsen KG; Reines E; Kennedy SH
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1391-400. PubMed ID: 23928296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.
    Mischoulon D; Shelton RC; Baer L; Bobo WV; Curren L; Fava M; Papakostas GI
    J Clin Psychiatry; 2017 Apr; 78(4):449-455. PubMed ID: 27835715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study.
    Kim JS; Lee EJ; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S;
    Lancet Psychiatry; 2017 Jan; 4(1):33-41. PubMed ID: 28012485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM; Loft H; Reines EH
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.